Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives

International Journal of Pharmaceutics

Volumn 454, Issue 2, 2013, Pages 653-659

  Arpicco, Silvia ^a   Stella, Barbara ^a   Schiavon, Oddone ^b   Milla, Paola ^a   Zonari, Daniele ^a   Cattel, Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Paclitaxel; Poly(ethylene glycol); Prodrugs; Stability

Indexed keywords

CARBAMIC ACID; ESTER; MACROGOL; PACLITAXEL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PH; PRIORITY JOURNAL; ROOM TEMPERATURE; STEREOSPECIFICITY;

PACLITAXEL; POLY(ETHYLENE GLYCOL); PRODRUGS; STABILITY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; DRUG COMPOUNDING; HT29 CELLS; HUMANS; MCF-7 CELLS; PACLITAXEL; POLYETHYLENE GLYCOLS; PRODRUGS;

EID: 84884148401     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.027     Document Type: Article

References (35)

1. Altstadt, T.J., Fairchild, C.R., Golik, J., Johnston, K.A., Kadow, J.F., Lee, F.Y., Long, B.H., Rose, W.C., Vyas, D.M., Wong, H., Wu, M.J., Wittman, M.D., 2001. Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476. J. Med. Chem. 44, 4577-4583. (Pubitemid 33144468)
2. Bonomi, P., Kim, K., Kusler, J., Johnson, D., 1997. Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer. Oncology (Williston Park, NY) 11, 9-10. (Pubitemid 27380986)
3. Bookman, M.A., McGuire, W.P., Kilpatrick, D., Keenan, E., Hogan, W.M., Johnson, S.W., Odwyer, P., Rowinsky, E., Gallion, H.H., Ozols, R.F., 1996. Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group. J. Clin. Oncol. 14, 1895-1902. (Pubitemid 26185464)
4. de Groot, F.M.H., van Berkom, L.W.A., Scheeren, H.W., 2000. Synthesis and biological evaluation of 2′-carbamate-linked and 2′-carbonate- linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin. J. Med. Chem. 43, 3093-3102. (Pubitemid 30626766)
5. Deutsch, H.M., Glinski, J.A., Hernandez, M., Haugwitz, R.D., Narayanan, V.L., Suffness, M., Zalkow, L.H., 1989. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor-activity. J. Med. Chem. 32, 788-792. (Pubitemid 19100192)
6. Dorr, R.T., 1994. Pharmacology and toxicology of Cremophor EL diluent. Ann. Pharmacother. 28, S11-S14. (Pubitemid 24139914)
7. Feng, X., Yuan, Y.J., Wu, J.C., 2002. Synthesis and evaluation of water-soluble paclitaxel prodrugs. Bioorg. Med. Chem. Lett. 12, 3301-3303. (Pubitemid 35248235)
8. Fjallskog, M.L., Frii, L., Bergh, J., 1993. IS Cremophor EL, solvent for paclitaxel, cytotoxic? Lancet 342, 873.
9. Greenwald, R.B., Pendri, A., Bolikal, D., Gilbert, C.W., 1994. Highly water-soluble taxol derivatives - 2′-polyethyleneglycol esters as potential prodrugs. Bioorg. Med. Chem. Lett. 4, 2465-2470. (Pubitemid 24324561)
10. Greenwald, R.B., Pendri, A., Bolikal, D., 1995. Highly water-soluble taxol derivatives: 7-polyethylene glycol carbamates and carbonates. J. Org. Chem. 60, 331-336.
11. Greenwald, R.B., Gilbert, C.W., Pendri, A., Conover, C.D., Xia, J., Martinez, A., 1996. Drug delivery systems: water soluble taxol 2′-poly(ethylene glycol) ester pro-drugs - design and in vivo effectiveness. J. Med. Chem. 39, 424-431.
12. Greenwald, R.B., Pendri, A., Conover, C.D., Lee, C., Choe, Y.H., Gilbert, C., Martinez, A., Xia, J., Wu, D.C., Hsue, M., 1998. Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity. Bioorg. Med. Chem. 6, 551-562. (Pubitemid 28264077)
13. Greenwald, R.B., Choe, Y.H., McGuire, J., Conover, C.D., 2003. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Deliv. Rev. 55, 217-250. (Pubitemid 36135917)
14. Hooftman, G., Herman, S., Schacht, E., 1996. Review: poly(ethylene glycol)s with reactive endgroups. II. Practical consideration for the preparation of protein-PEG conjugates. J. Bioact. Compat. Polym. 11, 135-159. (Pubitemid 26193706)
15. Kingston, D.G.I., Newman, D.J., 2007. Taxoids: cancer-fighting compounds from nature. Curr. Opin. Drug Discov. Devel. 10, 130-144. (Pubitemid 46438642)
16. Kumar, N., 1981. Taxol-induced polymerization of purified tubulin. Mechanism of action. J. Biol. Chem. 256, 10435-10441. (Pubitemid 12219438)
17. Lee, K.H., Chung, Y.J., Kim, Y.C., Song, S.J., 2005. Anti-tumor activity of paclitaxel prodrug conjugated with polyethylene glycol. Bull. Korean Chem. Soc. 26, 1079-1082.
18. Li, C., Yu, D.F., Inoue, T., Yang, D.J., Milas, L., Hunter, N.R., Kim, E.E., Wallace, S., 1996. Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug. Anticancer Drugs 7, 642-648. (Pubitemid 26348842)
19. Manfredi, J.J., Horwitz, S.B., 1984. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther. 25, 83-125. (Pubitemid 14035723)
20. Marupudi, N.I., Han, J.E., Li, K.W., Renard, V.M., Tyler, B.M., Brem, H., 2007. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin. Drug Saf. 6, 609-621. (Pubitemid 351308218)
21. Mathew, A.E., Mejillano, M.R., Nath, J.P., Himes, R.H., Stella, V.J., 1992. Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor-activity. J. Med. Chem. 35, 145-151.
22. Nabholtz, J.M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P., Klaassen, U., Namer, M., Bonneterre, J., Fumoleau, B., Winograd, B., 1996. Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J. Clin. Oncol. 14, 1858-1867. (Pubitemid 26185461)
23. Niethammer, A., Gaedicke, G., Lode, H.N., Wrasidlo, W., 2001. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility. Bioconjug. Chem. 12, 414-420. (Pubitemid 32464188)
24. Rowinsky, E.K., 1997. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med. 48, 353-374. (Pubitemid 27101837)
25. Ryu, B.-Y., Sohn, J.-S., Hess, M., Choi, S.-K., Choi, J.-K., Jo, B.-W., 2008. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs. J. Biomater. Sci. Polym. Ed. 19, 311-324. (Pubitemid 351311654)
26. Schiff, P.B., Fant, J., Horwitz, S.B., 1979. Promotion of microtubule assembly in vitro by taxol. Nature 277, 665-667. (Pubitemid 9114288)
27. Schoenmakers, R.G., van de Wetering, P., Elbert, D.L., Hubbell, J.A., 2004. The effect of the linker on the hydrolysis rate of drug-linked ester bonds. J. Control. Release 95, 291-300. (Pubitemid 38230043)
28. Skwarczynski, M., Hayashi, Y., Kiso, Y., 2006. Paclitaxel prodrugs: toward smarter delivery of anticancer agents. J. Med. Chem. 49, 7253-7269. (Pubitemid 44913386)
29. Stella, V.J., Nti-Addae, K.W., 2007. Prodrug strategies to overcome poor water solubility. Adv. Drug Deliv. Rev. 59, 677-694. (Pubitemid 47285410)
30. Sugahara, S., Kajiki, M., Kuriyama, H., Kobayashi, T.R., 2002. Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs. Biol. Pharm. Bull. 25, 632-641. (Pubitemid 39663261)
31. Takahashi, T., Tsukamoto, H., Yamada, H., 1998. Design and synthesis of a water-soluble taxol analogue: taxol-sialyl conjugate. Bioorg. Med. Chem. Lett. 8, 113-116. (Pubitemid 28021704)
32. Vyas, D.M., Vittorio, F., 1995. 3 Paclitaxel (taxol®) Formulation and Prodrugs, Pharmacochemistry Library. Elsevier, pp. 103-130.
33. Wang, S.D., Zhelev, N.Z., Duff, S., Fischer, P.M., 2006. Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin. Bioorg. Med. Chem. Lett. 16, 2628-2631.
34. Wani, M.C., Taylor, H.L., Wall, M.E., Coggon, P., McPhail, A.T., 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325-2327.
35. Weiss, R.B., Donehower, R.C., Wiernik, P.H., Ohnuma, T., Gralla, R.J., Trump, D.L., Baker, J.R., Vanecho, D.A., Vonhoff, D.D., Leylandjones, B., 1990. Hypersensitivity reactions from taxol. J. Clin. Oncol. 8, 1263-1268. (Pubitemid 20195638)